DOSSIER · 13F Holders · Q2 2026
TRAVERE THERAPEUTICS INC
5 institutions still hold TRAVERE THERAPEUTICS INC as of Q2 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP 89422G907·5 13F holders·last filed Jun 30, 2026
AI Holders Summary · Q2 2026
5 institutions reported TRAVERE THERAPEUTICS INC in Q2 2026. IMC-Chicago, LLC leads at 44.1% of the visible book.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.